Isansys Named as Finalist for OBN's Most Transformative Digital Healthcare Company Award

Isansys LifecareIsansys Lifecare is proud to announce it has been shortlisted in the Most Transformative Digital Healthcare Company category at the OBN Annual Awards 2019. The award recognises the significant uptake of the technology by healthcare providers and the real impact Isansys' technology is having on patients and hospitals globally.

Isansys Lifecare in Oxford has designed and developed the Patient Status Engine (PSE), the most advanced all-wireless patient monitoring system platform currently available. The PSE automates the basic process of taking patient observations, enabling the efficient collection of high quality, continuous, real-time vital sign data which is then used to build predictive indicators to help make better clinical decisions. The technology enables timely interventions that enhance the care and safety of patients, and, by providing robust and accurate physiological data, it has proved itself to be a new and powerful clinical system that is currently being adopted by an increasing number of healthcare providers globally.

OBN, a not-for-profit business network, provides support for innovative life science companies, corporate partners and investors in the UK. This year marks the 11th anniversary of their annual awards, which celebrate and recognise achievement in the industry.

Keith Errey, CEO of Isansys, says: "It is really pleasing as we come into our tenth year that we can say that we are established as the world's leading supplier of wireless physiological data monitoring systems. After all this time we can see healthcare providers starting to adopt the PSE as a new standard for in-ward and out-of-hospital monitoring and so bring the benefits of data-driven safer care to a greater number of patients.

"Our digital healthcare technology is delivering huge efficiencies to healthcare providers globally, improving patient outcomes and preventing avoidable deaths in the context of the immediate global healthcare crisis. We have seen the transformative effect of the technology in countries as diverse as Scandinavia and India, and we would hope the NHS can also benefit from this in the near future."

The winners will be announced on Thursday 7th of November at The Examination Schools of the University of Oxford.

About Isansys Lifecare Ltd

Isansys is a best in class digital healthcare company with an innovative patient monitoring platform, streamlining patient observations and enabling the early detection of deterioration in patients. With adequate warning of adverse events, clinicians can intervene more quickly and confidently, and patient outcomes can be improved. The Patient Status Engine (PSE), Isansys' proprietary technology platform, is a complete end-to-end, fully certified Class IIa CE-marked and class II 510(k) cleared medical device which uses wireless body-worn sensors to automatically collect and analyse vital signs continuously and in real-time using proprietary algorithms. This data is then streamed via a patient gateway network and delivered to the nurses' station or remotely to clinicians.

Clinical teams globally are using the data collected and analysed by the PSE to gain insights into the future health status of their patients, which is achieved through data-driven methods such as predictive algorithms, the automatic calculation of Early Warning Scores, and new physiologically based biomarkers. These enable clinicians and nurses to improve patient outcomes and reduce the costs of hospital stays and facilitate proactive care. The wireless nature of the PSE also means patients can be monitored in hospitals, in the community or at home.

Isansys a privately held company based in Abingdon, Oxfordshire, England.

Most Popular Now

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

AI Medical Receptionist Modernizing Doct…

A virtual medical receptionist named "Cassie," developed through research at Texas A&M University, is transforming the way patients interact with health care providers. Cassie is a digital-human assistant created by Humanate...

Using Data and AI to Create Better Healt…

Academic medical centers could transform patient care by adopting principles from learning health systems principles, according to researchers from Weill Cornell Medicine and the University of California, San Diego. In...

AI Tool Set to Transform Characterisatio…

A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI tool to better characterise the diversity of individual cells within...

AI Detects Hidden Heart Disease Using Ex…

Mass General Brigham researchers have developed a new AI tool in collaboration with the United States Department of Veterans Affairs (VA) to probe through previously collected CT scans and identify...

Human-AI Collectives Make the Most Accur…

Diagnostic errors are among the most serious problems in everyday medical practice. AI systems - especially large language models (LLMs) like ChatGPT-4, Gemini, or Claude 3 - offer new ways...

Northern Ireland Completes Nationwide Ro…

Go-lives at Western and Southern health and social care trusts mean every pathology service is using the same laboratory information management system; improving efficiency and quality. An ambitious technology project to...

Highland Marketing Announced as Official…

Highland Marketing has been named, for the second year running, the official communications partner for HETT Show 2025, the UK's leading digital health conference and exhibition. Taking place 7-8 October...

MHP-Net: A Revolutionary AI Model for Ac…

Liver cancer is the sixth most common cancer globally and a leading cause of cancer-related deaths. Accurate segmentation of liver tumors is a crucial step for the management of the...

Groundbreaking TACIT Algorithm Offers Ne…

Researchers at VCU Massey Comprehensive Cancer Center have developed a novel algorithm that could provide a revolutionary tool for determining the best options for patients - both in the treatment...

The Many Ways that AI Enters Rheumatolog…

High-resolution computed tomography (HRCT) is the standard to diagnose and assess progression in interstitial lung disease (ILD), a key feature in systemic sclerosis (SSc). But AI-assisted interpretation has the potential...